Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population
Authors
Keywords
Colorectal cancer, Fluorescent in situ hybridization, Immunohistochemistry techniques, Gene sequencing, Polymerase chain reaction, Fusion genes, Cancer detection and diagnosis, Cell fusion
Journal
PLoS One
Volume 10, Issue 12, Pages e0144731
Publisher
Public Library of Science (PLoS)
Online
2015-12-18
DOI
10.1371/journal.pone.0144731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
- (2013) J. Ying et al. ANNALS OF ONCOLOGY
- Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma
- (2013) Harumi Nakamura et al. JOURNAL OF CLINICAL PATHOLOGY
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment ofALK-Positive Non–Small Cell Lung Cancer
- (2012) Yung-Jue Bang ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Crizotinib
- (2011) Monique P. Curran DRUGS
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
- (2009) Salvatore Siena et al. JNCI-Journal of the National Cancer Institute
- Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders
- (2008) Genevieve Gallagher et al. CANCER GENETICS AND CYTOGENETICS
- Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
- (2008) U. McDermott et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started